MENU
+Compare
IXJ
ETF ticker: NYSE ARCA
AS OF
Apr 1 closing price
Price
$89.71
Change
-$1.49 (-1.63%)
Net Assets
3.95B

IXJ stock forecast, quote, news & analysis

The investment seeks to track the S&P Global 1200 Health Care IndexTM... Show more

Category: #Health
IXJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for IXJ with price predictions
Mar 31, 2025

IXJ in downward trend: price dove below 50-day moving average on March 26, 2025

IXJ moved below its 50-day moving average on March 26, 2025 date and that indicates a change from an upward trend to a downward trend. In of 44 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IXJ moved out of overbought territory on February 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IXJ as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IXJ turned negative on March 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

IXJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 312 cases where IXJ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets.

Market Cap

The average market capitalization across the iShares Global Healthcare ETF ETF is 87.46B. The market cap for tickers in the group ranges from 64.65K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Global Healthcare ETF ETF was 5%. For the same ETF, the average monthly price growth was 13%, and the average quarterly price growth was 45%. MOH experienced the highest price growth at 5%, while MRNA experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the iShares Global Healthcare ETF ETF was 24%. For the same stocks of the ETF, the average monthly volume growth was -16% and the average quarterly volume growth was 35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 56
Price Growth Rating: 53
SMR Rating: 59
Profit Risk Rating: 57
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
IXJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com